CLINICAL TRIALS PROFILE FOR SILDENAFIL CITRATE
✉ Email this page to a colleague
All Clinical Trials for SILDENAFIL CITRATE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00057759 ↗ | Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer | Completed | National Cancer Institute (NCI) | N/A | 2003-01-01 | RATIONALE: Sildenafil may be effective in helping patients who have undergone treatment for prostate cancer to have an erection for sexual activity and may improve sexual satisfaction and quality of life. PURPOSE: Randomized clinical trial to study the effectiveness of sildenafil in treating erectile dysfunction in patients who have undergone radiation therapy and hormone therapy for prostate cancer in clinical trial RTOG-9910. |
| NCT00057759 ↗ | Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer | Completed | Radiation Therapy Oncology Group | N/A | 2003-01-01 | RATIONALE: Sildenafil may be effective in helping patients who have undergone treatment for prostate cancer to have an erection for sexual activity and may improve sexual satisfaction and quality of life. PURPOSE: Randomized clinical trial to study the effectiveness of sildenafil in treating erectile dysfunction in patients who have undergone radiation therapy and hormone therapy for prostate cancer in clinical trial RTOG-9910. |
| NCT00080808 ↗ | Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer | Completed | National Cancer Institute (NCI) | Phase 2 | 2001-08-01 | RATIONALE: Nerve-sparing radical prostatectomy with nerve grafting followed by standard therapies for erectile dysfunction may be effective in helping patients with prostate cancer improve sexual satisfaction and quality of life. It is not yet known whether erectile dysfunction therapy and nerve-sparing prostatectomy are more effective with or without nerve grafting. PURPOSE: This randomized phase II trial is studying nerve grafting and standard therapy to see how well they work compared to standard therapy alone in treating erectile dysfunction in patients undergoing nerve-sparing radical prostatectomy for localized prostate cancer. |
| NCT00080808 ↗ | Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer | Completed | M.D. Anderson Cancer Center | Phase 2 | 2001-08-01 | RATIONALE: Nerve-sparing radical prostatectomy with nerve grafting followed by standard therapies for erectile dysfunction may be effective in helping patients with prostate cancer improve sexual satisfaction and quality of life. It is not yet known whether erectile dysfunction therapy and nerve-sparing prostatectomy are more effective with or without nerve grafting. PURPOSE: This randomized phase II trial is studying nerve grafting and standard therapy to see how well they work compared to standard therapy alone in treating erectile dysfunction in patients undergoing nerve-sparing radical prostatectomy for localized prostate cancer. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for SILDENAFIL CITRATE
Condition Name
Clinical Trial Locations for SILDENAFIL CITRATE
Trials by Country
Clinical Trial Progress for SILDENAFIL CITRATE
Clinical Trial Phase
Clinical Trial Sponsors for SILDENAFIL CITRATE
Sponsor Name
